Skip to main content
Premium Trial:

Request an Annual Quote

Ancestry: Ronald Park

Ancestry has appointed Ronald Park as executive VP of health and DNA. In this role, Park will lead the company's AncestryHealth division. Park joins Ancestry after 16 years at Roche Pharmaceuticals, including international leadership roles at Roche and US roles at Genentech. Most recently, Park was co-leader of Roche Pharmaceuticals' personalized healthcare center of excellence. Park has also previously worked for Kaiser Permanente and McKinsey and Company's healthcare practice, and was a physician at the University of California, Los Angeles.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.